Search
Lipoic acid
go.drugbank.com/drugs/DB00166ApprovedInvestigationalNutraceuticalA vitamin-like antioxidant.
Mixtures: VitaHealth L-Glutathione Plus, TIOPATI-B 600 MG/250 MG/1 MG FILM TABLET, 30 ADETCategories: Vitamin B Complex, Compounds used in a research, industrial, or household settingBenzalkonium
go.drugbank.com/drugs/DB11105ApprovedInvestigationalBenzalkonium is a quaternary ammonium compound used as a biocide, a cationic surfactant, and as a phase transfer agent [FDA Label]. … This salt is used in a great variety of international pharmaceutical products such as eye, ear, and nasal drops or sprays as an excipient ingredient serving as an antimicrobial preservative [FDA Label]
Mixtures: E-2 Cleanser Sanitizer, All Star Antiseptic Hand Soap E-2Categories: Compounds used in a research, industrial, or household settingDupilumab
go.drugbank.com/drugs/DB12159ApprovedInvestigationalDupilumab is a fully human monoclonal antibody of the immunoglobulin G4 subclass that binds to the interleukin-4 (IL-4) receptor, inhibiting the receptor signaling pathways. … [L7186,L7192,L41439] Dupilumab is currently under investigations for potential therapeutic use in diseases driven by allergic reactions or type 2 inflammation, such as pediatric atopic dermatitis, and
Categories: Interleukin-4 Receptor alpha Antagonist, Interleukin 4 Receptor alpha AntagonistsProducts: DUPİXENT 200 mg/1,14 ml ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 2 ADET, DUPİXENT 300 MG/2ML ENJEKSİYONLUK ÇÖZELTİ İÇEREN KULLANIMA HAZIR ENJEKTÖR, 2 ADETCetuximab
go.drugbank.com/drugs/DB00002ApprovedInvestigational[A227963] EGFR is often mutated in certain types of cancer and serves as a driver of tumorigenesis. … Cetuximab is a recombinant chimeric human/mouse IgG1 monoclonal antibody that competitively binds to epidermal growth factor receptor (EGFR) and competitively inhibits the binding of epidermal growth factor
Products: ERBITUX ® 5 MG/ML, ERBITUX® 5 MG/MLL-Dilinoleoyllecithin
go.drugbank.com/drugs/DB04372ExperimentalSynonyms: L-Dilinoleoyllecithin, 1,2-di-O-linoleoyl-sn-glycero-3-phosphocholineType 2 Diabetes
go.drugbank.com/conditions/DBCOND0030616Synonyms: Type 2 Diabetes Mellitus 2, Diabete Type 2Grade 2 Oligodendroglioma
go.drugbank.com/conditions/DBCOND0168503Drugs: VorasidenibSynonyms: Grade 2 OligodendrogliomaEnoxaparin
go.drugbank.com/drugs/DB01225ApprovedInvestigationalEnoxaparin is a common low-molecular-weight heparin (LMWH) used in the prevention and management of various thromboembolic disorders. … Initially approved by the FDA in 1993, it is administered by a subcutaneous or intravenous injection and marketed by several pharmaceutical companies.
Mixtures: ENOXAPARINA SODICA 40 MG JERINGAS PRELLENADASProducts: LOVENOX 50.000 IE (500 mg)/5 ml Injektionslösung in einer Durchstichflasche, ENOX 6000 ANTI-XA IU/0,6 ML 2 KULLANIMA HAZIR ENJEKTORFilgrastim
go.drugbank.com/drugs/DB00099ApprovedInvestigationalIt has an amino acid sequence identical to endogenous G-CSF, but it is non-glycosylated unlike the endogenous G-CSF and has an N-terminal methionine added in the sequence for expression in _E. Coli_. … [A245858] Tbo-filgrastim was approved by the FDA on August 29, 2012.[L36325] Filgrastim-sndz was approved on March 6, 2015 [L40768] and filgrastim-ayow was approved on March 2, 2022.
Synonyms: r-metHuG-CSFInternational brands: White-CVecuronium
go.drugbank.com/drugs/DB01339ApprovedInvestigationalA non-depolarizing neuromuscular blocking agent with shorter duration of action than pancuronium.
Categories: P-glycoprotein substratesProducts: VECURON INYECCION 2 ML (VECURONIO BROMURO 4 MG/ AMPOLLA), BROMURO DE VECURONIO 4 MG/VIAL POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLE